CRIS:Curis to Present at the 32nd Annual Cowen and Company Health Care Conference
LEXINGTON, Mass., Feb. 27, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS - News), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 32nd Annual Cowen and Company Health Care Conference at 1:30 p.m. EST on March 5, 2012, in Boston, MA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.